Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis

Objective: This review was performed to compare the efficacy and safety among hospitalized patients with COVID-19 who received baricitinib and those who received tocilizumab independently with placebo or the standard of care (SOC). Methods: Relevant databases were searched for randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherian, Jerin Jose, Eerike, Madhavi, Bagepally, Bhavani Shankara, Das, Saibal, Panda, Samiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624173/
https://www.ncbi.nlm.nih.gov/pubmed/36330085
http://dx.doi.org/10.3389/fphar.2022.1004308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624173/
https://www.ncbi.nlm.nih.gov/pubmed/36330085
http://dx.doi.org/10.3389/fphar.2022.1004308

Ejemplares similares